BRPI1006076A2 - composicoes farmaceuticas - Google Patents

composicoes farmaceuticas

Info

Publication number: BRPI1006076A2
Authority: BR; Brazil
Prior art keywords: pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 2009-01-13

Application number

BRPI1006076A

Other languages

English (en)

Inventor

Margit Mahlapuu

Mattias Munnich

Veronika Sjostrand

Original Assignee

Pharmasurgics In Sweden Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-01-13

Filing date

2010-01-12

Publication date

2016-04-19

2010-01-12 Application filed by Pharmasurgics In Sweden Ab filed Critical Pharmasurgics In Sweden Ab

2016-04-19 Publication of BRPI1006076A2 publication Critical patent/BRPI1006076A2/pt

2020-10-06 Publication of BRPI1006076B1 publication Critical patent/BRPI1006076B1/pt

2021-05-25 Publication of BRPI1006076B8 publication Critical patent/BRPI1006076B8/pt

Links

239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Surgery (AREA)
Zoology (AREA)
Heart & Thoracic Surgery (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)

BRPI1006076A 2009-01-13 2010-01-12 composições farmacêuticas BRPI1006076B8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE0900031-6		2009-01-13
SE0900031		2009-01-13
PCT/EP2010/050284 WO2010081800A2 (en)	2009-01-13	2010-01-12	New pharmaceutical compositions

Publications (3)

Publication Number	Publication Date
BRPI1006076A2 true BRPI1006076A2 (pt)	2016-04-19
BRPI1006076B1 BRPI1006076B1 (pt)	2020-10-06
BRPI1006076B8 BRPI1006076B8 (pt)	2021-05-25

Family

ID=42340142

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1006076A BRPI1006076B8 (pt)	2009-01-13	2010-01-12	composições farmacêuticas

Country Status (14)

Country	Link
US (4)	US20110306565A1 (pt)
EP (1)	EP2387390B1 (pt)
JP (1)	JP5646507B2 (pt)
KR (1)	KR101406743B1 (pt)
CN (1)	CN102271658B (pt)
AU (1)	AU2010205751B2 (pt)
BR (1)	BRPI1006076B8 (pt)
CA (1)	CA2748860C (pt)
ES (1)	ES2400466T3 (pt)
MX (1)	MX2011007462A (pt)
PL (1)	PL2387390T3 (pt)
RU (1)	RU2501566C2 (pt)
WO (1)	WO2010081800A2 (pt)
ZA (1)	ZA201105806B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2400466T3 (es)	2009-01-13	2013-04-10	Pergamum Ab	Composiciones que contienen ácido hialurónico para el tratamiento de heridas, cicatrices y la formación de adherencias postquirúrgicas
WO2012057381A1 (ko) *	2010-10-29	2012-05-03	주식회사 휴메딕스	히알루론산 및 ｌ-아르기닌을 함유하는 유착방지제
EP2481751A1 (en) *	2011-01-26	2012-08-01	PharmaSurgics in Sweden AB	Human lactoferrin derived peptides
WO2012154738A1 (en)	2011-05-09	2012-11-15	The Cleveland Clinic Foundation	Composition and method to improve intestinal health
FR3002452B1 (fr) *	2013-02-28	2016-02-12	Dermaconcept Jmc	Composition dermatologique antimicrobienne topique
CN111281978A (zh) *	2019-08-19	2020-06-16	上海交通大学医学院附属第九人民医院	透明质酸基载体及其制备方法在抗瘢痕中的应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4141973A (en)	1975-10-17	1979-02-27	Biotrics, Inc.	Ultrapure hyaluronic acid and the use thereof
US5080893A (en)	1988-05-31	1992-01-14	University Of Florida	Method for preventing surgical adhesions using a dilute solution of polymer
SE8900586L (sv)	1989-02-21	1990-08-22	Pharmacia Ab	Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader
JP2818056B2 (ja) *	1990-09-07	1998-10-30	森永乳業株式会社	抗菌性ペプチドおよび抗菌剤
IT1263394B (it) *	1993-07-30	1996-08-05	Fidia Advanced Biopolymers Srl	Composizioni farmaceutiche per uso topico a base di acido ialuronico e suoi derivati
JPH0881387A (ja) *	1994-09-09	1996-03-26	Morinaga Milk Ind Co Ltd	創傷治癒剤
US5690961A (en)	1994-12-22	1997-11-25	Hercules Incorporated	Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
RU2177332C2 (ru)	1995-08-29	2001-12-27	Фидиа Адвансд Биополимерз, С.Р.Л.	Биоматериал для предотвращения послеоперационных спаек, включающий производные гиалуроновой кислоты (варианты) и способ предотвращения послеоперационных спаек ткани
US6037331A (en)	1996-07-19	2000-03-14	Poly-Med, Inc.	Compositions for prevention of inflammation and adhesion formation uses thereof
US6515016B2 (en) *	1996-12-02	2003-02-04	Angiotech Pharmaceuticals, Inc.	Composition and methods of paclitaxel for treating psoriasis
ATE259654T1 (de) *	1998-06-26	2004-03-15	Nutricia Nv	Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
SE9804614A0 (en) *	1998-07-06	2000-01-07	A+ Science Invest Ab	New peptides and use thereof
US7218503B2 (en)	1998-09-30	2007-05-15	Lam Research Corporation	Method of determining the correct average bias compensation voltage during a plasma process
US6521223B1 (en)	2000-02-14	2003-02-18	Genzyme Corporation	Single phase gels for the prevention of adhesions
WO2002009792A1 (en)	2000-07-28	2002-02-07	Anika Therapeutics, Inc.	Bioabsorbable composites of derivatized hyaluronic acid
KR100375299B1 (ko)	2000-10-10	2003-03-10	주식회사 엘지생명과학	히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
CA2430130A1 (en)	2000-11-28	2002-06-06	Focal, Inc.	Polyalkylene glycol viscosity-enhancing polymeric formulations
EP1284143A1 (en) *	2001-08-17	2003-02-19	Sifi S.p.A	A process for the preparation of pharmaceutical formulations containing lactoferrin description
SE0200667D0 (sv) *	2002-03-05	2002-03-05	A & Science Invest Ab	Novel use of cytokine inhibitors
KR100523953B1 (ko)	2002-08-27	2005-10-25	주식회사 엘지생명과학	천연다당류와 히알루론산의 마이크로비드 및 이의 제조 방법
BRPI0413833A (pt) *	2003-09-11	2006-10-24	Novozymes As	célula hospedeira microbiana recombinante, construção de ácido nucleico, método para produzir uma enzima e/ou um agente antimicrobiano, produto de fusão, aditivo e composição de ração animal, animal não humano transgênico ou produtos ou elementos deste, usos do produto de fusão, da co-expressão de um agente antimicrobiano e uma enzima, e de um peptìdeo de proteção, e, método para identificar um peptìdeo de proteção
US7455248B2 (en)	2004-03-17	2008-11-25	Genzyme Corporation	Powder delivery device
ITPD20040245A1 (it)	2004-10-08	2005-01-08	Fidia Advanced Biopolymers Srl	Biomateriali costituiti da acido ialuronico solfatato e gellano utilizzabili nella prevenzione delle adesioni spinali
WO2006047744A2 (en) *	2004-10-26	2006-05-04	Agennix Incorporated	Compositions of lactoferrin related peptides and uses thereof
WO2007009062A2 (en) *	2005-07-13	2007-01-18	Anthrogenesis Corporation	Treatment of leg ulcers using placenta derived collagen biofabric
EP2050461A1 (en) *	2007-10-19	2009-04-22	PharmaSurgics in Sweden AB	Peptides based on the sequence of human lactoferrin and their use
ES2400466T3 (es)	2009-01-13	2013-04-10	Pergamum Ab	Composiciones que contienen ácido hialurónico para el tratamiento de heridas, cicatrices y la formación de adherencias postquirúrgicas

2010
- 2010-01-12 ES ES10700405T patent/ES2400466T3/es active Active
- 2010-01-12 CN CN2010800040649A patent/CN102271658B/zh not_active Expired - Fee Related
- 2010-01-12 KR KR1020117017898A patent/KR101406743B1/ko not_active Expired - Fee Related
- 2010-01-12 JP JP2011544890A patent/JP5646507B2/ja not_active Expired - Fee Related
- 2010-01-12 CA CA2748860A patent/CA2748860C/en active Active
- 2010-01-12 MX MX2011007462A patent/MX2011007462A/es active IP Right Grant
- 2010-01-12 RU RU2011133224/15A patent/RU2501566C2/ru active
- 2010-01-12 EP EP10700405A patent/EP2387390B1/en not_active Not-in-force
- 2010-01-12 US US13/143,875 patent/US20110306565A1/en not_active Abandoned
- 2010-01-12 BR BRPI1006076A patent/BRPI1006076B8/pt not_active IP Right Cessation
- 2010-01-12 PL PL10700405T patent/PL2387390T3/pl unknown
- 2010-01-12 AU AU2010205751A patent/AU2010205751B2/en not_active Ceased
- 2010-01-12 WO PCT/EP2010/050284 patent/WO2010081800A2/en not_active Ceased
2011
- 2011-08-08 ZA ZA2011/05806A patent/ZA201105806B/en unknown
2014
- 2014-08-13 US US14/458,637 patent/US9878019B2/en not_active Expired - Fee Related
2017
- 2017-12-21 US US15/851,025 patent/US10471129B2/en active Active
2019
- 2019-08-29 US US16/555,708 patent/US11000574B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU2010205751B2 (en)	2013-05-02
HK1164701A1 (en)	2012-09-28
EP2387390B1 (en)	2012-11-28
CN102271658A (zh)	2011-12-07
US20180200341A1 (en)	2018-07-19
US11000574B2 (en)	2021-05-11
WO2010081800A3 (en)	2010-11-25
CN102271658B (zh)	2013-06-12
BRPI1006076B1 (pt)	2020-10-06
CA2748860C (en)	2014-09-23
JP5646507B2 (ja)	2014-12-24
CA2748860A1 (en)	2010-07-22
US20200188490A1 (en)	2020-06-18
RU2011133224A (ru)	2013-02-20
PL2387390T3 (pl)	2013-12-31
ZA201105806B (en)	2012-04-25
US20110306565A1 (en)	2011-12-15
US10471129B2 (en)	2019-11-12
WO2010081800A2 (en)	2010-07-22
MX2011007462A (es)	2011-08-03
RU2501566C2 (ru)	2013-12-20
US9878019B2 (en)	2018-01-30
EP2387390A2 (en)	2011-11-23
JP2012515151A (ja)	2012-07-05
BRPI1006076B8 (pt)	2021-05-25
ES2400466T3 (es)	2013-04-10
AU2010205751A1 (en)	2011-07-28
KR101406743B1 (ko)	2014-06-20
US20140349949A1 (en)	2014-11-27
KR20110114610A (ko)	2011-10-19

Legal Events

Date	Code	Title	Description
2017-09-26	B25A	Requested transfer of rights approved	Owner name: PERGAMUM AB (SE)
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2017-10-17	B25G	Requested change of headquarter approved	Owner name: PERGAMUM AB (SE)
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-05-15	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2019-07-16	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2020-07-28	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2020-10-06	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/10/2020, OBSERVADAS AS CONDICOES LEGAIS.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/01/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2024-11-05	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 15A ANUIDADE.
2025-02-25	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2809 DE 05-11-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI1012539A2 (pt)	2016-03-29	composições farmacêuticas
DK3097925T3 (da)	2019-08-05	Farmaceutisk sammensætning
BRPI1004940A2 (pt)	2018-06-19	composição farmacêutica
LT3061445T (lt)	2023-09-25	Labai koncentruotos farmacinės kompozicijos
SMT201600350B (it)	2016-11-10	Composizioni farmaceutiche
SMT201700095B (is)	2017-03-08	Composizioni farmaceutiche per inalazione
SMT201700008B (it)	2017-03-08	Composizione farmaceutica
DK2395834T3 (da)	2019-09-02	Natriumnitrit-holdige farmaceutiske sammensætninger
DK3078664T3 (da)	2019-05-13	Antiparasitiske dihydroazol-sammensætninger
EP2488022A4 (en)	2014-02-19	Compositions
EP2451274A4 (en)	2014-04-02	Pharmaceutical compositions
UY33161A (es)	2011-07-29	Composiciones plaguicidas
BRPI1015939A2 (pt)	2016-09-27	composição farmacêutica
DK3246018T3 (da)	2022-01-17	Farmaceutisk sammensætning
SMT201400069B (it)	2014-07-07	Formulazione farmaceutica
BR112012012108A2 (pt)	2016-04-05	composição farmacêutica compreendendo propofol
DOP2011000396A (es)	2012-02-15	Composiciones novedosas
IT1394400B1 (it)	2012-06-15	Composizioni farmaceutiche
BRPI1010690A2 (pt)	2016-03-15	composições
DK2391349T3 (da)	2014-11-03	Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
EE201300005A (et)	2013-08-15	Ravimkoostis
BR112012000831A2 (pt)	2019-09-24	compostos, composições farmacêuticas e métodos relacionados
CO6801722A2 (es)	2013-11-29	Composiciones farmacéuticas
BRPI0922653A2 (pt)	2016-01-05	preparação farmacêutica
BR112012001340A2 (pt)	2016-03-15	composições farmacêuticas